Digestive Diseases and Sciences

, Volume 41, Issue 3, pp 458–461 | Cite as

High seroprevalence ofHelicobacter pylori in diabetes mellitus patients

  • B. Oldenburg
  • R. J. A. Diepersloot
  • J. B. L. Hoekstra
Esophageal, Gastric, And Duodenal Disorders

Abstract

To assess the prevalence ofHelicobacter pylori in diabetes mellitus, a serological test was used to detect antibodies toH. pylori in patients with diabetes mellitus. Within six months, 45 insulin-dependent, 98 non-insulin-dependent, and a control group of 159 outpatients were enrolled in this study. The age adjusted seroprevalence rates ofHelicobacter pylori were determined using a commercial anti-Helicobacter pylori IgG and IgA ELISA (Bio-Rad). The prevalence rates increased with age in all age groups until 60–70 years. In diabetic patients, the frequency ofHelicobacter pylori infection was higher than in control subjects in nearly all age groups, reaching significance in three age categories for NIDDM patients and in one age category in IDDM patients. This higher seroprevalence could not be explained by differences in socioeconomic status or use of antibiotics.

Key words

Helicobacter pylori seroprevalence diabetes mellitus 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dixon MF:Campylobacter pylori and chronic gastritis.In Campylobacter pylori and Gastroduodenal Disease. BJ Rathbone, RV Heatley (eds). Oxford, Blackwell Scientific Publications, 1989, pp 106–116Google Scholar
  2. 2.
    Tytgat GNJ, Axon ATR, Dixon MF, Graham DY, Lee A, Marchall BJ:Helicobacter pylori: Causal agent in peptic ulcer disease? Working party report of the world congress of gastroenterology, 1990, pp 36–45Google Scholar
  3. 3.
    Feng Y, Wang Y:Campylobacter pylori in patients with gastritis, peptic ulcer and carcinoma of the stomach in Lanzhou, China. Lancet 1:1055–1056, 1988Google Scholar
  4. 4.
    Feldman M, Schiller LR: Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98:378–384, 1983Google Scholar
  5. 5.
    Katz LA, Spiro HM: Gastrointestinal manifestations of diabetes. N Engl J Med 275:1350–1361, 1966Google Scholar
  6. 6.
    Scarpello JHB, Sladen GE: Progress report: Diabetes and the gut. Gut 19:1153–1162, 1978Google Scholar
  7. 7.
    Feldman M, Corbett DB, Ramsey EJ, Walsh JH, Richardson CT: Abnormal gastric function in longstanding, insulin-dependent diabetic patients. Gastroenterology 77:12–17, 1979Google Scholar
  8. 8.
    Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Evaluation of a commercial ELISA for serodiagnosis ofHelicobacter pylori infection. J Clin Pathol 44:326–328, 1991Google Scholar
  9. 9.
    Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E: Epidemiology ofHelicobacter pylori in an asymptomatic population in the United States: Effect of age, race and socioeconomic status. Gastroenterology 100:1495–1501, 1991Google Scholar
  10. 10.
    Sitas F, Forman D, Yarnell JWG, Burr ML, Elwood PC, Pedley S, Marks KJ:Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 32:25–28, 1991Google Scholar
  11. 11.
    Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM: Intrafamilial clustering ofHelicobacter pylori infection. N Engl J Med 322:359–363, 1990Google Scholar
  12. 12.
    Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ, Malaty HM, Evans DG: Seroepidemiology ofHelicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci 36:1084–1088, 1991Google Scholar
  13. 13.
    Diepersloot RJA, Bouter KP, Beyer WEP, Hoekstra JBL, Masurel N: Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 30:397–401, 1987Google Scholar
  14. 14.
    Glass EJ, Stewart J, Matthews DM, Collier A, Clarke BF, Weir DM: Impairment of monocyte “lectin-like” receptor activity in type 1 (insulin dependent) diabetic patients. Diabetologia 30:228–231, 1987Google Scholar
  15. 15.
    Ohno Y, Aoki N, Nishimura A: In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1072–1077, 1993Google Scholar
  16. 16.
    Hussein MJ, Alviggi L, Millwand BA, Leslie RDG, Pyke DA, Vergani D: Evidence that the reduced number of natural killer cells in type 1 (insulin dependent) may be genetically determinated. Diabetologia 30:907–911, 1987Google Scholar
  17. 17.
    Nolan CM, Beaty HN, Bagdade JD: Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 27:889–894, 1978Google Scholar
  18. 18.
    Blaser MJ:Helicobacter pylori: Its role in disease. Clin Infect Dis 15:386–393, 1992Google Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • B. Oldenburg
    • 1
  • R. J. A. Diepersloot
    • 1
  • J. B. L. Hoekstra
    • 1
  1. 1.From the Department of Internal Medicine and Laboratory for Public HealthDiakonessen HospitalUtrechtThe Netherlands

Personalised recommendations